丁鹏,徐臣年,杨剑

• 1:空军军医大学西京医院心血管外科

摘要(Abstract)：

<正>经导管主动脉瓣置换术(transcatheteraorticvalve replacement,TAVR)是一项用于治疗主动脉瓣疾病的新型介入技术。经过十几年的迅速发展,TAVR治疗中、重度主动脉瓣狭窄(aortic stenosis,AS)的可行性和安全性已经在全球范围内得到认可。《2017年美国心脏协会(American Heart Association,AHA)/美国心脏病学会(AmericanCollegeof Cardiology,ACC)心脏瓣膜疾病患者管理指南》~([1])已经将其列

关键词(KeyWords)： 经导管主动脉瓣置换术;主动脉瓣关闭不全;人工瓣膜

Abstract:

Keywords:

基金项目(Foundation): 军队后勤重大课题（ALJ17J001）;; 西京医院学科助推计划（XJZT15ZL01）;; 国家自然科学基金（81774415）;; 国家重点研发计划（2016YFC1101000）

作者(Author): 丁鹏,徐臣年,杨剑

参考文献(References)：

• [1] Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease:A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol, 2017, 70(2):252-289.
• [2]李捷，孙英皓，李光，等.经导管主动脉瓣置换术在外科低危主动脉瓣狭窄患者中的疗效分析.中国介入心脏病学杂志，2018, 26(11):619-621.
• [3]汪浩，沙巴尔·肉孜阿吉，马翔，等.经导管主动脉瓣置换术相关并发症的现状与进展.中国介入心脏病学杂志，2017, 25(10):594-597.
• [4] Hildebrandt HA, Erbel R, Kahlert P. Compassionate use of the selfexpandable medtronic CoreValve prosthesis for the treatment of pure aortic regurgitation in a patient at prohibitive risk for surgical valve replacement. Catheter Cardiovasc Interv, 2013, 82(7):E939-E943.
• [5]陈翔，葛均波.经导管主动脉瓣置入术治疗严重主动脉瓣反流的研究进展.中华心血管病杂志，2015, 43(7):639-641.
• [6] Franzone A, Piccolo R, Siontis GC, et al. Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation:a systematic review. JACC Cardiovasc Interv, 2016,9(22):2308-2317.
• [7] Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe:The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 2003, 24(13):1231-1243.
• [8] Dujardin KS, Enriquez-Sarano M, Schaff HV, et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation, 1999, 99(14):1851-1857.
• [9] Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease:the Siegburgfirst-in-man study.Circulation, 2006, 114(15):1616-1624.
• [10] Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol, 2013, 61(15):1577-1584.
• [11] Wei L, Liu H, Zhu L, et al. A New Transcatheter aortic valve replacement system for predominant aortic regurgitation implantation of the J-Valve and early outcome. JACC Cardiovasc Interv, 2015, 8(14):1831-1841.
• [12] Seiff ert M, Bader R, Kappert U, et al. Initial German experience with transapical implantation of a second-generation transcatheter heart valve f or the treatment of aortic regurgitation. JACC Cardiovasc Interv, 2014, 7(10):1168-1174.
• [13] D'Ancona G, Pasic M, Buz S, et al. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device. Ann Thorac Surg, 2012, 93(4):e89-e91.
• [14] Pasupati S, Devlin G, Davis M, et al. Transcatheter solution for pure aortic insufficiency. JACC Cardiovasc Imaging, 2014, 7(3):315-318.
• [15] Sawaya FJ, Deutsch MA, Seiff ert M, et al. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses:results from an international registry study. JACC Cardiovasc Interv,2017, 10(10):1048-1056.
• [16] Schlingloff F, Schafer U, Frerker C, et al. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation:procedural outcome, haemodynamic data and followup. Interact Cardiovasc Thorac Surg, 2014, 19(3):388-393.
• [17] Wendt D, Kahlert P, Pasa S, et al. Transapical transcatheter aortic valve for severe aortic regurgitation:expanding the limits. JACC Cardiovasc Interv, 2014, 7(10):1159-1167.
• [18] Zhu D, Chen W, Peng L, et al. Valve sizing for pure aortic regurgitation during transcatheter aortic valve replacement:deformation dynamic of the aortic annulus in different valve pathology may be different. JACC Cardiovasc Interv, 2015, 8(2):372-373.
• [19] Holzhey D, Linke A, Treede H, et al. Intermediate follow-up results from the multicenter engager European pivotal trial. Ann Thorac Surg, 2013, 96(6):2095-2100.
• [20] Zhu D, Wei L, Cheung A, et al. Treatment of pure aortic regurgitation using a second-generation transcatheter aortic valve implantation system. J Am Coll Cardiol, 2016, 67(23):2803-2805.
• [21] Zhu D, Chen Y, Guo Y, et al. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system-J-Valve for high-risk patients with aortic valve diseases:Initial results with90-day follow-up. Int J Cardiol, 2015, 199:155-162.
• [22] Zhu D, Chen Y, Zhang J, et al. Transapical implantation of a new second-generation transcatheter heart valve in patients with pure aortic regurgitation:a preliminary report. Interact Cardiovasc Thorac Surg, 2015, 20(6):860-862.
• [23] Cerillo AG, Griese D, Berti S. Successful percutaneous implantation of symetis ACURATE neo transcatheter aortic bioprosthesis for the treatment of pure aortic regurgitation. Catheter Cardiovasc Interv,2016, 88(2):319-323.
• [24] Webb JG, Sathananthan J. Transcatheter aortic valve replacement for pure noncalcific aortic regurgitation is coming, but not yet primetime. JACC Cardiovasc Interv, 2016, 9(22):2318-2319.
• [25] Wohrle J, Rodewald C, Rottbauer W. Transfemoral aortic valve implantation in pure native aortic valve insufficiency using the repositionable and retrievable lotus valve. Catheter Cardiovasc Interv, 2016, 87(5):993-995.
• [26] Takagi H, Hari Y, Kawai N, et al. Meta-analysis and metaregression of transcatheter aortic valve implantation for pure native aortic regurgitation. Heart Lung Circ, 2019.[Epub ahead of print]
• [27] Wernly B, Eder S, Navarese EP, et al. Transcatheter aortic valve replacement for pure aortic valve regurgitation：“on-label” versus“off-label” use of TAVR devices. Clin Res Cardiol, 2019,108(8):921-930.
• [28] Stachon P, Kaier K, Heidt T, et al. Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015. Catheter Cardiovasc Interv, 2019.[Epub ahead of print]
• [29] De Backer O, Pilgrim T, Simonato M, et al. Usefulness of transcatheter aortic valve implantation for treatment of pure native aortic valve regurgitation. Am J Cardiol, 2018, 122(6):1028-1035.